Cancer stem cells: Controversies in multiple myeloma

Journal of Molecular Medicine

Volumn 87, Issue 11, 2009, Pages 1079-1085

  Brennan, Sarah K ^a,b   Matsui, William ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; B cells; Cancer stem cells; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN J CHAIN;

CANCER GROWTH; CANCER RELAPSE; CANCER STEM CELL; CARCINOGENESIS; CELL ACTIVITY; DISEASE MARKER; FUNCTIONAL ASSESSMENT; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; MULTIPLE MYELOMA; NONHUMAN; PHENOTYPE; REVIEW;

ANIMALS; HUMANS; MULTIPLE MYELOMA; NEOPLASTIC STEM CELLS;

EID: 70449522900     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0531-7     Document Type: Review

References (59)

1. RA Kyle SV Rajkumar 2004 Multiple myeloma N Engl J Med 351 1860 1873 10.1056/NEJMra041875 1:CAS:528:DC%2BD2cXptFChtLk%3D 15509819 (Pubitemid 39426321)
2. LM Pilarski G Hipperson K Seeberger E Pruski RW Coupland AR Belch 2000 Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice Blood 95 1056 1065 1:CAS:528:DC%2BD3cXotV2ntA%3D%3D 10648422
3. LM Pilarski K Seeberger RW Coupland A Eshpeter JJ Keats BJ Taylor AR Belch 2002 Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice Exp Hematol 30 221 228 10.1016/S0301-472X(01) 00788-3 1:CAS:528:DC%2BD38XhslWgtb4%3D 11882359 (Pubitemid 34203728)
4. W Matsui CA Huff Q Wang MT Malehorn J Barber Y Tanhehco BD Smith CI Civin RJ Jones 2004 Characterization of clonogenic multiple myeloma cells Blood 103 2332 2336 10.1182/blood-2003-09-3064 1:CAS:528:DC%2BD2cXitlCjs74%3D 14630803 (Pubitemid 38326254)
5. W Matsui Q Wang JP Barber S Brennan BD Smith I Borrello I McNiece L Lin RF Ambinder C Peacock DN Watkins CA Huff RJ Jones 2008 Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance Cancer Res 68 190 197 10.1158/0008-5472.CAN-07-3096 1:CAS:528:DC%2BD1cXoslSi 18172311
6. S Yaccoby B Barlogie J Epstein 1998 Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations Blood 92 2908 2913 1:CAS:528:DyaK1cXms1eltbk%3D 9763577
7. S Yaccoby J Epstein 1999 The proliferative potential of myeloma plasma cells manifest in the SCID-hu host Blood 94 3576 3582 1:CAS:528: DyaK1MXnsVansrw%3D 10552969
8. CV Cox RS Evely A Oakhill DH Pamphilon NJ Goulden A Blair 2004 Characterization of acute lymphoblastic leukemia progenitor cells Blood 104 2919 2925 10.1182/blood-2004-03-0901 1:CAS:528:DC%2BD2cXhtVagu73J 15242869 (Pubitemid 39434980)
9. AA George J Franklin K Kerkof AJ Shah M Price E Tsark D Bockstoce D Yao N Hart S Carcich R Parkman GM Crooks K Weinberg 2001 Detection of leukemic cells in the CD34+CD38{-} bone marrow progenitor population in children with acute lymphoblastic leukemia Blood 97 3925 10.1182/blood.V97.12.3925 1:CAS:528:DC%2BD3MXksVOqsbc%3D 11389036
10. M Hotfilder S Rottgers A Rosemann H Jurgens J Harbott J Vormoor 2002 Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal Blood 100 640 646 10.1182/blood.V100.2.640 1:CAS:528:DC%2BD38XlsVWgtb8%3D 12091359 (Pubitemid 34761130)
11. M Hotfilder S Rottgers A Rosemann A Schrauder M Schrappe R Pieters H Jurgens J Harbott J Vormoor 2005 Leukemic Stem Cells in Childhood High-Risk ALL/t(9;22) and t(4;11) Are Present in Primitive Lymphoid-Restricted CD34+CD19- Cells Cancer Res 65 1442 1449 10.1158/0008-5472.CAN-04-1356 1:CAS:528: DC%2BD2MXhsFKqtL4%3D 15735032 (Pubitemid 40270173)
12. L Wang H O'Leary J Fortney LF Gibson 2007 Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells Blood 110 3334 3344 10.1182/blood-2007-01-068122 1:CAS:528:DC%2BD2sXht1yqurrO 17638851 (Pubitemid 350106327)
13. CA O'Brien A Pollett S Gallinger JE Dick 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 106 110 10.1038/nature05372 17122772 (Pubitemid 46067310)
14. P Dalerba SJ Dylla P Ik R Liu X Wang RW Cho T Hoey A Gurney EH Huang DM Simeone AA Shelton G Parmiani C Castelli MF Clarke 2007 Phenotypic characterization of human colorectal cancer stem cells Proceedings of the National Academy of Sciences 104 10158 10163 10.1073/pnas.0703478104 1:CAS:528:DC%2BD2sXmvVCntLw%3D (Pubitemid 47175279)
15. C Li DG Heidt P Dalerba CF Burant L Zhang V Adsay M Wicha MF Clarke DM Simeone 2007 Identification of pancreatic cancer stem cells Cancer Res 67 1030 1037 10.1158/0008-5472.CAN-06-2030 1:CAS:528:DC%2BD2sXht1yns70%3D 17283135 (Pubitemid 46270758)
16. PC Hermann SL Huber T Herrler A Aicher JW Ellwart M Guba CJ Bruns C Heeschen 2007 Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 313 323 10.1016/j.stem.2007.06.002 1:CAS:528:DC%2BD2sXhtFagu7vN 18371365 (Pubitemid 47355323)
17. X He L Marchionni DE Hansel Yu Wayne A Sood J Yang G Parmigiani W Matsui DM Berman 2009 Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma Stem Cells 27 1487 1495 10.1002/stem.92 1:CAS:528:DC%2BD1MXhtVGjsb%2FN 19544456
18. K Chan I Espinosa J Kim L Ailles G Zahilay H Gill J Presti M van de Rijn P Beachy L Shortliffe I Weissman 2008 Molecular profiling reveals heterogeneity of active self-renewal pathways in bladder cancer stem cells AACR Meeting Abstracts 2008 4998
19. SK Singh C Hawkins ID Clarke JA Squire J Bayani T Hide RM Henkelman MD Cusimano PB Dirks 2004 Identification of human brain tumour initiating cells Nature 432 396 401 10.1038/nature03128 1:CAS:528:DC%2BD2cXpvVCjtbY%3D 15549107 (Pubitemid 39551674)
20. T-A Read MP Fogarty SL Markant RE McLendon Z Wei DW Ellison PG Febbo RJ Wechsler-Reya 2009 Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma Cancer Cell 15 135 147 10.1016/j.ccr.2008.12.016 1:CAS:528:DC%2BD1MXltFSmtLY%3D 19185848
21. M Al Hajj MS Wicha A Benito-Hernandez SJ Morrison MF Clarke 2003 Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci USA 100 3983 3988 10.1073/pnas.0530291100 1:CAS:528:DC%2BD3sXivFSqtbs%3D 12629218 (Pubitemid 36418143)
22. C Ginestier MH Hur E Charafe-Jauffret F Monville J Dutcher M Brown J Jacquemier P Viens CG Kleer S Liu A Schott D Hayes D Birnbaum MS Wicha G Dontu 2007 ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 555 567 10.1016/j.stem.2007. 08.014 1:CAS:528:DC%2BD2sXhsVahtrvF 18371393 (Pubitemid 350056407)
23. T Lapidot C Sirard J Vormoor B Murdoch TC-CJ Hoang M Minden B Paterson MA Caligiuri JE Dick 1994 A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 645 648 10.1038/367645a0 1:STN:280:DyaK2c7ltVKrsg%3D%3D 7509044 (Pubitemid 24067706)
24. D Bonnet JE Dick 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 730 737 10.1038/nm0797-730 1:CAS:528:DyaK2sXkt1GrtLY%3D 9212098 (Pubitemid 27298715)
25. HD Hemmati I Nakano JA Lazareff M Masterman-Smith DH Geschwind M Bronner-Fraser HI Kornblum 2003 Cancerous stem cells can arise from pediatric brain tumors Proceedings of the National Academy of Sciences 100 15178 15183 10.1073/pnas.2036535100 1:CAS:528:DC%2BD3sXpvFaqu70%3D (Pubitemid 37518036)
26. S Aigner C Ramos A Hafezi-Moghadam M Lawrence J Friederichs P Altevogt K Ley 1998 CD24 mediates rolling of breast carcinoma cells on P-selectin FASEB J 12 1241 1251 1:CAS:528:DyaK1cXlvFWrsrY%3D 9737727
27. H Joensuu PJ Klemi S Toikkanen S Jalkanen 1993 Glycoprotein CD44 expression and its association with survival in breast cancer Am J Pathol 143 867 874 1:STN:280:DyaK3szntVGltw%3D%3D 8362982
28. ME Prince R Sivanandan A Kaczorowski GT Wolf MJ Kaplan P Dalerba IL Weissman MF Clarke LE Ailles 2007 Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proceedings of the National Academy of Sciences 104 973 978 10.1073/pnas. 0610117104 1:CAS:528:DC%2BD2sXhtVSitLk%3D (Pubitemid 46154721)
29. MA Goodell M Rosenzweig H Kim DF Marks M DeMaria G Paradis SA Grupp CA Sieff RC Mulligan RP Johnson 1997 Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species Nat Med 3 1337 1345 10.1038/nm1297-1337 1:CAS:528: DyaK2sXnvVGjsLg%3D 9396603 (Pubitemid 28011033)
30. DA Hess TE Meyerrose L Wirthlin TP Craft PE Herrbrich MH Creer JA Nolta 2004 Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity Blood 104 1648 1655 10.1182/blood-2004-02-0448 1:CAS:528:DC%2BD2cXns1OktL4%3D 15178579 (Pubitemid 39202270)
31. SJ Dylla L Beviglia IK Park C Chartier J Raval L Ngan K Pickell J Aguilar S Lazetic S Smith-Berdan MF Clarke T Hoey J Lewicki AL Gurney 2008 Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy PLoS ONE 3 e2428 10.1371/journal.pone.0002428 18560594
32. MS Wicha S Liu G Dontu 2006 Cancer stem cells: an old idea-a paradigm shift Cancer Res 66 1883 1890 10.1158/0008-5472.CAN-05-3153 1:CAS:528: DC%2BD28XhsFamtbw%3D 16488983 (Pubitemid 43294892)
33. RJ Jones CD Gocke YL Kasamon CB Miller B Perkins JP Barber MS Vala JM Gerber LL Gellert M Siedner MV Lemas S Brennan RF Ambinder W Matsui 2009 Circulating clonotypic B cells in classic Hodgkin lymphoma Blood 113 5920 5926 10.1182/blood-2008-11-189688 10.1182/blood-2008-11-189688 1:CAS:528: DC%2BD1MXnsVSktr0%3D 19188663
34. DC Taussig F Miraki-Moud F njos-Afonso DJ Pearce K Allen C Ridler D Lillington H Oakervee J Cavenagh SG Agrawal TA Lister JG Gribben D Bonnet 2008 Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells Blood 112 568 575 10.1182/blood-2007-10-118331 1:CAS:528:DC%2BD1cXpsVajurg%3D 18523148
35. D Fang TK Nguyen K Leishear R Finko AN Kulp S Hotz PA Van Belle X Xu DE Elder M Herlyn 2005 A tumorigenic subpopulation with stem cell properties in melanomas Cancer Res 65 9328 9337 10.1158/0008-5472.CAN-05-1343 1:CAS:528:DC%2BD2MXhtFWmu7zI 16230395 (Pubitemid 41508000)
36. T Schatton GF Murphy NY Frank K Yamaura AM Waaga-Gasser M Gasser Q Zhan S Jordan LM Duncan C Weishaupt RC Fuhlbrigge TS Kupper MH Sayegh MH Frank 2008 Identification of cells initiating human melanomas Nature 451 345 349 10.1038/nature06489 1:CAS:528:DC%2BD1cXnt1Gisg%3D%3D 18202660
37. E Quintana M Shackleton MS Sabel DR Fullen TM Johnson SJ Morrison 2008 Efficient tumour formation by single human melanoma cells Nature 456 593 598 10.1038/nature07567 1:CAS:528:DC%2BD1cXhsVGlur7K 19052619
38. MH Bakkus C Heirman I Van Riet B Van Camp K Thielemans 1992 Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation Blood 80 2326 2335 1:CAS:528:DyaK3sXhs1Oiu7o%3D 1421403
39. SS Sahota R Leo TJ Hamblin FK Stevenson 1997 Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells Blood 89 219 226 1:CAS:528:DyaK2sXhsF2mtg%3D%3D 8978295
40. MH Bakkus RI Van B Van Camp K Thielemans 1994 Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell Br J Haematol 87 68 74 10.1111/j.1365-2141.1994. tb04872.x 1:CAS:528:DyaK2MXhvVyktw%3D%3D 7947257
41. D Billadeau G Ahmann P Greipp B Van Ness 1993 The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell J Exp Med 178 1023 1031 10.1084/jem.178.3.1023 1:CAS:528:DyaK3sXlsFyiu7s%3D 8350044
42. PL Bergsagel AM Smith A Szczepek MJ Mant AR Belch LM Pilarski 1995 In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain Blood 85 436 447 1:CAS:528:DyaK2MXjtVWiurk%3D 7529064
43. BJ Chen J Epstein 1996 Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells Blood 87 1972 1976 1:CAS:528:DyaK28XhtlGgsbg%3D 8634446
44. T Rasmussen J Kastrup LM Knudsen HE Johnsen 1999 High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myeloma Br J Haematol 105 265 267 1:STN:280:DyaK1M3ltVGgsg%3D%3D 10233390
45. F Caligaris-Cappio L Bergui L Tesio G Pizzolo F Malavasi M Chilosi D Campana CB van G Janossy 1985 Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma J Clin Invest 76 1243 1251 10.1172/JCI112080 1:CAS:528:DyaL2MXlvFCktLg%3D 2931452
46. L Bergui M Schena G Gaidano M Riva F Caligaris-Cappio 1989 Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma J ExpMed 170 613 618 10.1084/jem.170.2.613 1:CAS:528:DyaL1MXltlahsLc%3D
47. AW Hamburger SE Salmon 1977 Primary bioassay of human tumor stem cells Science 197 461 463 10.1126/science.560061 1:STN:280:DyaE2s3hsF2htA%3D%3D 560061
48. J Kirshner KJ Thulien LD Martin C Debes Marun T Reiman AR Belch LM Pilarski 2008 A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma Blood 112 2935 2945 10.1182/blood-2008-02-142430 10.1182/blood-2008-02-142430 1:CAS:528:DC%2BD1cXht1SrtbzK 18535198
49. DT Scadden 2006 The stem-cell niche as an entity of action Nature 441 1075 1079 10.1038/nature04957 1:CAS:528:DC%2BD28XmtlahsrY%3D 16810242 (Pubitemid 43990719)
50. CS Mitsiades NS Mitsiades PG Richardson NC Munshi KC Anderson 2007 Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment J Cell Biochem 101 950 968 10.1002/jcb.21213 1:CAS:528:DC%2BD2sXnvVWjsro%3D 17546631 (Pubitemid 47040875)
51. WJ Chng O Glebov PL Bergsagel WM Kuehl 2007 Genetic events in the pathogenesis of multiple myeloma Best Practice & Research Clinical Haematology 20 571 596 10.1016/j.beha.2007.08.004 1:CAS:528:DC%2BD2sXhsVSksb%2FI (Pubitemid 350215376)
52. KLM Boylan MA Gosse SE Staggs S Janz S Grindle GS Kansas BG Van Ness 2007 A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma Cancer Res 67 4069 4078 10.1158/0008-5472.CAN-06-3699 1:CAS:528: DC%2BD2sXltVyku7k%3D 17483317 (Pubitemid 46815051)
53. M Chesi DF Robbiani M Sebag WJ Chng M Affer R Tiedemann R Valdez SE Palmer SS Haas AK Stewart R Fonseca R Kremer G Cattoretti PL Bergsagel 2008 AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies Cancer Cell 13 167 180 10.1016/j.ccr.2008.01.007 1:CAS:528:DC%2BD1cXitFWrsL4%3D 18242516 (Pubitemid 351163163)
54. DR Carrasco K Sukhdeo M Protopopova R Sinha M Enos DE Carrasco M Zheng M Mani J Henderson GS Pinkus N Munshi J Horner EV Ivanova A Protopopov KC Anderson G Tonon RA DePinho 2007 The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis Cancer Cell 11 349 360 10.1016/j.ccr.2007. 02.015 1:CAS:528:DC%2BD2sXksFWjsro%3D 17418411 (Pubitemid 46518314)
55. CHM Jamieson LE Ailles SJ Dylla M Muijtjens C Jones JL Zehnder J Gotlib K Li MG Manz A Keating CL Sawyers IL Weissman 2004 Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML N Engl J Med 351 657 667 10.1056/NEJMoa040258 1:CAS:528:DC%2BD2cXms1Oktbg%3D 15306667 (Pubitemid 39063268)
56. I Hanamura JP Stewart Y Huang F Zhan M Santra JR Sawyer K Hollmig M Zangarri M Pineda-Roman F van Rhee F Cavallo B Burington J Crowley G Tricot B Barlogie JD Shaughnessy Jr 2006 Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation Blood 108 1724 1732 10.1182/blood-2006-03-009910 1:CAS:528:DC%2BD28Xpt1Slurs%3D 16705089 (Pubitemid 44316143)
57. R Fonseca S Van Wier W Chng R Ketterling M Lacy A Dispenzieri P Bergsagel S Rajkumar P Greipp M Litzow 2006 Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma Leukemia 20 2034 2040 10.1038/sj.leu.2404403 1:CAS:528:DC%2BD28XhtFWnsLrO 17024118 (Pubitemid 44614894)
58. J Drach J Ackermann E Fritz E Kromer R Schuster H Gisslinger M DeSantis N Zojer M Fiegl S Roka J Schuster R Heinz H Ludwig H Huber 1998 Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy Blood 92 802 809 1:CAS:528: DyaK1cXltVOrs7s%3D 9680348
59. M Portier JP Moles GR Mazars P Jeanteur R Bataille B Klein C Theillet 1992 p53 and RAS gene mutations in multiple myeloma Oncogene 7 2539 2543 1:CAS:528:DyaK3sXitVWlsg%3D%3D 1461658